Ozempics half-life is around one week
The new study, which targeted overweight or obese patients with cardiovascular disease, is the first to show that semaglutide can help the hearts of people without diabetes too
Adults with recorded evidence of prior type 1 or type 2 diabetes, myocardial infarction, stroke, or heart failure were excluded from the study
Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease, bolstering physicians excitement about an already-exploding class of new medicines
To achieve optimal results, it is essential to combine semaglutide treatment with lifestyle modifications, such as adopting a balanced diet, engaging in regular physical activity, and developing healthy coping mechanisms for stress and emotional eating